Cargando…

The Metabolic Landscape of RAS-Driven Cancers from biology to therapy

Our understanding of how the RAS protein family, and in particular mutant KRAS promote metabolic dysregulation in cancer cells has advanced significantly over the last decade. In this Review, we discuss the metabolic reprogramming mediated by oncogenic RAS in cancer, and elucidating the underlying m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukhopadhyay, Suman, Vander Heiden, Matthew G., McCormick, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045781/ https://www.ncbi.nlm.nih.gov/pubmed/33870211 http://dx.doi.org/10.1038/s43018-021-00184-x

Ejemplares similares

K-Ras protein as a drug target
por: McCormick, Frank
Publicado: (2016)

Tumor RAS Gene Expression Levels Are Influenced by the Mutational Status of RAS Genes and Both Upstream and Downstream RAS Pathway Genes
por: Stephens, Robert M, et al.
Publicado: (2017)

A Covalent Calmodulin Inhibitor as a Tool to Study Cellular Mechanisms of K-Ras-Driven Stemness
por: Okutachi, Sunday, et al.
Publicado: (2021)

ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications
por: Yi, Ming, et al.
Publicado: (2020)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
por: Tatli, Ozge, et al.
Publicado: (2021)

Acetate metabolism in cancer cells
por: Hosios, Aaron M, et al.
Publicado: (2014)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
por: Gillies, Taryn E, et al.
Publicado: (2020)

Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy
por: Bartolacci, Caterina, et al.
Publicado: (2021)

The importance of serine metabolism in cancer
por: Mattaini, Katherine R., et al.
Publicado: (2016)

Delineating the RAS Conformational Landscape
por: Parker, Mitchell I., et al.
Publicado: (2022)

Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers
por: Mattox, Tyler E., et al.
Publicado: (2019)

Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers
por: Scharpf, Robert B., et al.
Publicado: (2022)

TSPAN6 is a suppressor of Ras-driven cancer
por: Humbert, Patrick O., et al.
Publicado: (2022)

Microenvironmental regulation of cancer cell metabolism: implications for experimental design and translational studies
por: Muir, Alexander, et al.
Publicado: (2018)

Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors
por: Lai, Lick Pui, et al.
Publicado: (2022)

KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
por: Tran, Timothy H., et al.
Publicado: (2021)

Exploiting the bad eating habits of Ras-driven cancers
por: White, Eileen
Publicado: (2013)

Ferroptosis: A Specific Vulnerability of RAS-Driven Cancers?
por: Andreani, Cristina, et al.
Publicado: (2022)

Targeting K-Ras and apoptosis-driven cellular transformation in cancer
por: Godwin, Isha, et al.
Publicado: (2021)

ETS-targeted therapy: can it substitute for MEK inhibitors?
por: Tetsu, Osamu, et al.
Publicado: (2017)

Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts
por: Dunnett-Kane, V., et al.
Publicado: (2020)

Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
por: Liefwalker, Daniel F., et al.
Publicado: (2021)

Correction: TSPAN6 is a suppressor of Ras-driven cancer
por: Humbert, Patrick O., et al.
Publicado: (2022)

Proximal Protein Interaction Landscape of RAS Paralogs
por: Béganton, Benoît, et al.
Publicado: (2020)

Consistency for the tree bootstrap in respondent-driven sampling
por: Green, A K B, et al.
Publicado: (2020)

RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
por: Nichols, Robert J., et al.
Publicado: (2018)

Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy
por: Luengo, Alba, et al.
Publicado: (2014)

Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer
por: Wang, Man-Tzu, et al.
Publicado: (2019)

Machine learning–driven multiscale modeling reveals lipid-dependent dynamics of RAS signaling proteins
por: Ingólfsson, Helgi I., et al.
Publicado: (2022)

Secondary-metabolite biosynthesis and metabolism
por: Petroski, Richard, et al.
Publicado: (1992)

Metabolic requirements for cancer cell proliferation
por: Keibler, Mark A., et al.
Publicado: (2016)

Emerging RAS-directed therapies for cancer
por: Conroy, Michael, et al.
Publicado: (2021)

Blocking anaplerotic entry of glutamine to TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs
por: Saqcena, Mahesh, et al.
Publicado: (2014)

Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells
por: Guo, Jessie Yanxiang, et al.
Publicado: (2016)

Current landscape of research ethics consultation services: National survey results
por: Taylor, Holly A., et al.
Publicado: (2022)

Synthetic lethality in KRas-driven cancer cells created by glutamine deprivation
por: Mukhopadhyay, Suman, et al.
Publicado: (2015)

Role of autophagy in K-RAS- and B-RAF-driven lung cancers
por: White, Eileen
Publicado: (2014)

Molecular genetics and cellular events of K-Ras-driven tumorigenesis
por: Jinesh, G G, et al.
Publicado: (2018)

K-Ras Binds Calmodulin-Related Centrin1 with Potential Implications for K-Ras Driven Cancer Cell Stemness
por: Manoharan, Ganesh babu, et al.
Publicado: (2023)

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
por: Commisso, Cosimo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v3uci0c96e2dnf55j8h35lv39c